Frazier Life Sciences Management, L.P. — 13F holdings

Frazier Life Sciences Management, L.P. reported 41 holdings worth $4.59B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. MIRM MIRUM PHARMACEUTICALS INC — $899M (19.6%)
2. NAMS NEWAMSTERDAM PHARMA COMPANY — $613M (13.3%)
3. ERAS Erasca Inc — $458M (10.0%)
4. MBX MBX BIOSCIENCES INC — $367M (8.0%)
5. ARQT ARCUTIS BIOTHERAPEUTICS INC — $259M (5.6%)
6. TRVI Trevi Therapeutics Inc — $185M (4.0%)
7. KRYS KRYSTAL BIOTECH INC — $179M (3.9%)
8. MAZE MAZE THERAPEUTICS INC — $150M (3.3%)
9. PHAT PHATHOM PHARMACEUTICALS INC — $135M (2.9%)
10. PVLA PALVELLA THERAPEUTICS INC NE — $135M (2.9%)